Taken together, these data suggest PPARγ is required for normal PTEN expression in malignant mammary tumours, but PTEN is not an early PPARγ downstream signaling target in benign mammary tumours, and may be a fruitful area for research in future studies. The gene discussed is PPARG; the disease is breast cancer.